Oral and i.v. formulations of gatifloxacin cleared for U.S. market.
Miller
J L
JL
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000737:chemistry; D017277:Drug Approval; D004348:Drug Labeling; D024841:Fluoroquinolones; D000077734:Gatifloxacin; D006801:Humans; D007275:Injections, Intravenous; D014481:United States
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D000077734:Gatifloxacin